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PreviewsThese studies potentially provide new tar-
gets to treat diseases, such as inflamma-
tion and cancer, for which nonapoptotic
activities of CD95 are proving important
(Peter et al., 2007).
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In this issue of Immunity, Luber et al. (2010) report a comprehensive quantitative proteome of in vivo mouse
spleen dendritic cell (DC) subsets: a data set of encyclopedic value already revealing that DC subsets exploit
different RNA sensors for virus recognition.Denditic cells (DCs) are key players in the
immune response against invading patho-
gens and provide a direct link between
inate and adaptive immune responses.
As antigen-presenting cells, DCs are able
to recognize, take up, and process patho-
gens, dying cells, and malignant cells into
antigenic fragments that are subsequently
presented on major histocompatibility
complexes to T cells to initiate adaptive
immune responses.
In recent years it has become clear that
DCs do not represent one homogeneous
population of antigen-presenting cells
but rather form a plethora of distinct sub-
types, defined by specific cell-surface
markers. For some subsets, specialized
immune functions have been recognized
(Shortman et al., 2009). For example in
mice, CD8a+ spleenDCswere recognized
as most efficient in cross-presentation
of antigens derived from dying cells
in MHC class I, a function less well
performed by other CD8a DC spleensubsets. Although CD8a is not expressed
by human DCs, BDCA3+ blood DCs
might represent the human counterpart.
Furthermore, plasmacytoid DCs, a subset
present both in mice and men, are known
to master the initiation of antiviral immune
responses by secretion of large amounts
of type I interferons. However, in spite of
all efforts to elucidate the nature of these
phenotypically defined subsets, func-
tional differences as well as the relation
between subsets in the human and the
murine system are still incompletely
resolved.
Murine splenic DCs are certainly the
most widely studied cells in DC biology.
At steady state, two major DC subsets
can be distinguished: conventional DCs
(cDCs) and plasmacytoid DCs (pDCs).
Spleen cDCs can be further subdivided
into CD8a+CD4 DCs, CD8aCD4+ DCs,
and CD8a CD4 double negative (DN)
DCs. Thus far, mainly comparative micro-
array studies have been performed inattempts to elucidate functional speciali-
zations in these splenic subsets (Robbins
et al., 2008). RNA expression, however,
does not necessarily predict protein
abundance. Transcripts can be transla-
tional nonactive, RNA and protein may
differ in stability, or protein expression
can be controlled by posttranslational
modifications rather than at a transcrip-
tional level.
In this issue of Immunity, Luber et al.
(2010) use their long-standing expertise
in proteomics to gain more insight in the
differences that exist between these
mouse spleen DC subsets. This was not
an easy task given that the quantitative
comparison of such rare cell populations
in vivo by proteomics was until now
greatly hampered by the lack of tech-
nology and the large costs involved,
especially when taking into account the
number of biological replicates required
for statistical significance. Novel algo-
rithms were developed for label-freeFebruary 26, 2010 ª2010 Elsevier Inc. 149
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Figure 1. Mouse Spleen DCs Respond to Viruses via Different Receptors
DC subsets exploit different pathogen sensors to recognize the same virus, resulting in distinct signals
(antigen presentation, costimulation, and cytokines) toward other components of the innate and adaptive
immunesystem.CD4+ andCD4CD8a double negative (DN)DCsare directly activated bycell-intrinsic viral
infectionvia cytoplasmicRLHsandmaypresent viral antigensexploiting the classical route to loadMHC I .By
contrast,CD8a+DCs lackcytoplasmicviral sensorsandare thereforenotactivatedbycell-intrinsic viral infec-
tion. They can, however, be activated through TLR 3 via the endocytosis or phagocytosis of apoptoticmate-
rial fromother infectedcells (cell-extrinsic infection).CD8a+DCsareable topresent antigens fromvirusesand
infected cells onMHC I via cross-presentation. The absence of cytoplasmic viral sensors in CD8a+ DCsmay
explainwhy theyare suchgoodcross-presentors. pDCsexpressbothcytoplasmicandendosomal detection
systems but detection of virus via endosomal TLR7 probably dominates because these cells are protected
from cell-intrinsic viral infection through the secretion of high amounts of type I interferon. pDCs are capable
of cross-presenting antigens, but the physiological relevance of this is not yet fully understood.
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Previewsquantification of protein abundance in
CD8a+CD4, CD8aCD4+, DN DCs and
pDCs sorted from mouse spleens by
flow cytometry. Providing quantitative
protein data for more than 5000 proteins
for each subset, this undoubtedly is the
most comprehensive protein analysis of
DC subsets so far, representing a valuable
resource for the immunology community.
Moreover this study shows that proteo-
mics analysis of in vivo cell populations
requires only relatively small numbers of
cells (<2 3 106) without the need for
labeling.
Proteomics confirmed expression of
subsets specific proteins, including CD8,
DEC205, CD36, Necl, and IRF8, all abun-
dant in CD8a+ DCs, and CD4, SIRPa,
CD11b, 33D1, and IRF4 in CD4+ DCs.
Luber et al. (2010) also describe subset
specific expression of CD97 by CD8a+
DCs that was not previously observed
by microarray expression.
Early detection of invading patho-
gens—key to DC function—is mediated
by pattern-recognition receptors (PRRs)
and was investigated in more detail.
Expression of Toll-like receptors (TLRs)
known to recognize pathogens at the
cell surface or within the endosomal sys-
tem was validated as predominant ex-
pression of TLR 7 in CD4+ DCs, DN DCs150 Immunity 32, February 26, 2010 ª2010 Eand pDCs (Pichlmair and Reis e Sousa,
2007), whereas TLR3 and the more newly
described TLR12 and TLR13 were most
abundant in CD8a+ DCs, although pDCs
also expressed TLR12. Specific expres-
sion of TLR12 and TLR13 on CD8a+ DCs
is of special interest because no ligands
have been identified so far. Identifying
these ligands will definitely shed light
on both receptor as well as CD8a+ DC
function.
TLRs mainly recognize cell-extrinsic
viral infection via the uptake of material
from other (apoptotic) infected cells (Iwa-
saki and Medzhitov, 2010). An important
finding of this proteomic analysis involves
the expression and function of cytosolic
viral sensors that detect viruses invading
the cytoplasm (cell-intrinsic viral infec-
tion). It is for these receptors and their
downstream effectors that Luber et al.
(2010) found large differences between
the four DC subsets. Cytoplasmic nucleic
acid receptors were highly represented in
CD4+ DCs, DN DCs, and pDCs but were
virtually absent in CD8a+ DCs (Luber
et al., 2010). In particular, cytoplasmic
RNA sensors of the RIG-I-like helicases
(RLHs) RIG-I and MDA-5 were markedly
less abundant in CD8a+ DCs. This was
also true for the DNA sensor DAI and
many downstream signaling componentslsevier Inc.involved in nucleic acid sensing, indicating
this difference not only concerns sensing
receptors but also holds for downstream
signaling pathways. Consistent with this
finding, CD8a+ DCs were, in contrast to
the other subsets, not activated upon viral
infection, neither bySendai nor influenzaA
virus, both known activators of RIG-I. Ex-
ploiting mice models lacking expression
of TLR adaptor Myd88 or the RIG-I and
MDA-5 adaptor MAVS, Luber et al.
(2010) showed that MAVS but not Myd88
was required for this activation, further
demonstrating the involvement of the
RLH pathway. Interestingly, in spite of
the presence of abundant RLH in pDCs,
MAVS was not required for the activation
of pDCs, consistent with the finding that
TLR7 mainly mediates pDCs responses
to influenza and Sendai viruses (Diebold
et al., 2004) and with a recent report that
pDCs may protect against infection
through secretion of high amounts of
type I interferon (IFN) (Kumagai et al.,
2009).
These proteome and functional data
show that DC subsets respond differently
to viral infection (Figure 1). One of the key
questions is now whether these different
viral response strategies also relate to
their ability to induce adaptive immunity.
Is the main task of CD4+ and DN now
to directly initiate adaptive immune re-
sponses against infecting viruses, or is
their activation providing signals (e.g.,
type I IFN) to notify other, surrounding
antigen-presenting cells to perform this
task? Because RLHs are expressed by
most mammalian cells (Iwasaki and
Medzhitov, 2010), we can ask whether
this system has a specialized function in
DC or whether DCs express these cyto-
solic sensors at higher amounts than
non-APCs. Perhaps CD8a+ DCs are the
only ‘‘odd’’ ones out there. With respect
to the absence of RLHs and NLRs in
CD8a+ DCs, Luber et al. (2010) hypothe-
size that CD8a+ DCs do not express cyto-
solic viral sensors to get a head start on
the cross-presentation of viral antigens.
In concordance with this, they show that
infected CD8a+ cells are still able to
cross-present. Indeed, a higher ‘‘signal
to noise’’ ratio may be preserved within
the CD8a+ DCs by the absence of RLH,
facilitating cross-presentation of antigens
from endosomal-ingested apoptotic-
infected cells to proceed without simulta-
neous ‘‘disturbing’’ signals from cytosolic
Immunity
Previewsviral sensors. It will be important to obtain
further support for this potential link
between the ability to cross-present and
the absence of cytosolic viral sensors
from presumed human equivalents such
as the BDCA3+ myeloid DC.
From these observed functional differ-
ences between DC subsets, it is clear
that this proteome encyclopedia of
mouse DC subsets harbors a wealth of
information, and probably many more
functional differences will be uncovered.
Moreover, although proteomics and
microarray are both valuable tools, they
become extremely powerful when used
in combination. RNA and protein ex-
pression clearly confirm and also supple-
ment each other as we have recently
demonstrated in studying human mono-
cyte-derived DC maturation (Buschow
et al., 2010). When comparing such
related data sets at the pathway level,
analyzing sets of coherent genes,
many more similarities are revealed than
when comparing single-gene expression
(Beltrame et al., 2009; Buschow et al.,2010). In this respect it will extremely
interesting to see how these protein
data set relate to, are supported by, or
could complement already existing mi-
croarray libraries of spleen DC subsets
(Robbins et al., 2008). Furthermore,
analysis should be expanded to include
human DC subsets as well, comparing
mouse and human DCs at the pathway
level and searching for similarities
beyond the expression of single-marker
proteins. The speed with which we can
extract such further useful information
from large data sets, however, is highly
dependent on the accuracy and com-
pleteness of current pathway databases.
For allowing optimal detection of pathway
variation between cell subsets, pathways
need to be curated and structured into
small highly specific nonoverlapping
modules. Valuable proteomics studies
such as those provided by Luber et al.
(2010) for maximal exploitation await
accurate pathway curation by experts
of distinct fields from the scientific
community.Immunity 32,REFERENCES
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